논문KCI 등재
Letter 1 regarding “Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma”
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
참고문헌 (2)
- Yeo YH, "Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma", Clin Mol Hepatol, 29, pp.721~732 (2023)
- Kleebayoon A, "Artificial intelligence, chatbots, plagiarism and basic honesty : Comment", Cell Mol Bioeng, 16, pp.173~174 (2023)
관련 논문AI추천
Letter 1 regarding “Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma”Hassam Ali대한간학회 · Clinical and Molecular Hepatology2023 · 제29권 제3호Correspondence on Letter 1 regarding “Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma”Jamil S. Samaan, Wee Han Ng, Yee Hui Yeo대한간학회 · Clinical and Molecular Hepatology2023 · 제29권 제3호Letter 2 regarding “Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma”Bin Sheng, Hanyun Liu, Hongwei Ji, Lili Xu, Linlin Ren, Liwei Wu, Susan Cheng, Tien Yin Wong, Yangang Wang, Yaxing Wang, Yih Chung Tham, Ying Chen, Yiwen Zhang, Zepeng Mu대한간학회 · Clinical and Molecular Hepatology2024 · 제30권 제1호Letter 2 regarding “Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma”Amnuay Kleebayoon, Viroj Wiwanitkit대한간학회 · Clinical and Molecular Hepatology2023 · 제29권 제3호Correspondence on Letter regarding “Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma”Ju Dong Yang, Yee Hui Yeo대한간학회 · Clinical and Molecular Hepatology2024 · 제30권 제1호Correspondence on Letter 2 regarding “Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma”Jamil S. Samaan, Wee Han Ng, Yee Hui Yeo대한간학회 · Clinical and Molecular Hepatology2023 · 제29권 제3호
이 간행물의 다른 논문 (21건)
Recent advances in the management of hepatocellular carcinomaJu Dong Yang, Andrew E. Hendifar, Nicholas N. Nissen, Kambiz Kosari, Steven A. Miles, Arsen Osipov, Jun Gong, Kamya Sankar, Ekaterina K. Koltsovapp. 1-15Congratulatory remarksYoon Jun Kimpp. 1-1KASL clinical practice guidelines for noninvasive tests to assess liver fibrosis in chronic liver diseaseBeom Kyung Kim, Eun Joo Lee, Eun Ju Cho, Young-Joo Jin, Hee Yeon Kim, Ji Won Han, Moon Young Kim, Seung-seob Kim, Dae Won Jun, Seung Up Kim, Jihyun An, Minjong Lee, Jung Hwan Yu, Yuri Cho, Young Eun Chon, Han Ah Lee, Sang Gyune Kim, YoungRok Choi, Mi Na Kim, Yu Rim Shinpp. 5-105Taiwan Association for the Study of the Liver-Taiwan Society of Cardiology Taiwan position statement for the management of metabolic dysfunction- associated fatty liver disease and cardiovascular diseasesHan-Chieh Lin, Chi-Yi Chen, Chih-Lin Lin, Yi-Hsiang Huang, Ming-Lung Yu, Jia-Horng Kao, Chao-Yung Wang, Chung-Lieh Hung, Ting-Hsing Chao, Chern-En Chiang, Yi-Heng Li, Tsung-Hsien Lin, Tzung-Dau Wang, Ping-Yen Liu, Yen-Wen Wu, Jee-Fu Huang, Chun-Jen Liu, Cheng-Yuan Peng, Chun-Yen Lin, Pin-Nan Cheng, Wen-Jone Chen, Charles Jia-Yin Hou, Ming-Ling Chang, Chia-Chi Wang, Wei-Ting Changpp. 16-36Comparison of four histological scoring systems for autoimmune hepatitis to improve diagnostic sensitivityEun Ju Cho, 이경분, 김혜령, Sook-Hyang Jeong, Soomin Ahn, Gilhyang Kimpp. 37-48